Business Description
Biomind Labs Inc
NAICS : 541714
SIC : 3741
ISIN : CA0907021012
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 15.91 | |||||
Equity-to-Asset | -7.08 | |||||
Debt-to-Equity | -0.01 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 36.8 | |||||
9-Day RSI | 47.22 | |||||
14-Day RSI | 53.47 | |||||
6-1 Month Momentum % | 150 | |||||
12-1 Month Momentum % | -36.44 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.1 | |||||
Quick Ratio | 0.1 | |||||
Cash Ratio | 0.1 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 0.11 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -769.35 | |||||
ROIC % | -446.89 | |||||
ROC (Joel Greenblatt) % | -3830.74 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -14.15 | |||||
EV-to-EBITDA | -14.42 | |||||
EV-to-FCF | -23.14 | |||||
Earnings Yield (Greenblatt) % | -7.07 | |||||
FCF Yield % | -4.29 |